Chronic Disease Management Software: Tracking Diabetes and Hypertension Patients in Africa

The Rising NCD Burden in Cameroon and Sub-Saharan Africa

Non-communicable diseases (NCDs) are the fastest-growing health challenge in sub-Saharan Africa. While communicable diseases still dominate health budgets, the dual burden of infectious and chronic conditions is placing unprecedented pressure on health systems that were never designed for long-term care. WHO projects that NCDs will account for more than 50% of deaths in sub-Saharan Africa by 2030.

In Cameroon, diabetes prevalence is estimated at approximately 6% of the adult population — roughly 1.5 million people — while hypertension affects an estimated 30% of adults, making it the most prevalent NCD in the country. Both conditions are substantially underdiagnosed: a patient with hypertension may live for years without symptoms before presenting with a stroke or myocardial infarction. The scale of the problem, combined with the long-term care requirements these conditions impose, makes digital chronic disease management not a technical upgrade but a clinical necessity.

Why Chronic Disease Care Differs From Acute Care

Acute illness — malaria, a fracture, pneumonia — has a defined beginning, treatment course, and end. Chronic disease management operates on an entirely different model. A patient with type 2 diabetes diagnosed at 45 may require structured clinical follow-up for the next 30 or 40 years. Each clinical encounter is not a standalone episode but a point in a longitudinal trajectory that must be evaluated in the context of all previous visits.

This fundamental difference has profound implications for health information systems. A simple patient registration and episode-of-care system is insufficient. What is needed is:

• A persistent longitudinal record that accumulates laboratory results, medication histories, and clinical observations over years
• Trend visualisation so clinicians can see whether glycaemic or blood pressure control is improving, stable, or deteriorating
• Automated alerts when values fall outside safe ranges or when a scheduled review has been missed
• Population-level reporting that gives facility managers a view of how the entire NCD patient panel is performing

Without these capabilities, each clinic visit becomes an isolated encounter rather than a guided step in a long-term care plan.

Building a Digital Chronic Disease Register

The foundation of digital NCD management is a structured patient register — a list of all patients with a given condition, their current status, and when they are next due for review. In many Cameroonian facilities today, NCD registers exist as handwritten notebooks that are difficult to search, impossible to analyse, and frequently incomplete.

A digital chronic disease register in an HMS provides:

• Complete patient list with condition, date of diagnosis, and current medication
• Review schedule showing which patients are due for follow-up this week, this month, or overdue
• Summary indicators for the panel: percentage with controlled blood pressure, percentage with HbA1c below 7%, percentage lost to follow-up in the last three months
• Risk stratification grouping patients by complication risk so that the highest-risk patients receive the most frequent follow-up

A well-maintained digital register allows a single NCD coordinator to manage a patient panel of several hundred effectively — triaging attention to those who need it most rather than relying on patients to self-manage their recall visits.

HbA1c and Fasting Glucose Tracking for Diabetes

Glycaemic control is the central goal of diabetes management. Two laboratory parameters drive clinical decisions: fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c), which reflects average blood glucose over the preceding 2–3 months.

An HMS diabetes module must capture both values at each visit and display them as a chronological trend. A single elevated HbA1c is concerning; a series of rising HbA1c values over three consecutive visits is a clinical emergency requiring urgent medication adjustment.

Key features include:

• HbA1c trend chart with target range (typically below 7% for most adults, below 8% for elderly or high-risk patients)
• FPG chart with pre- and post-meal values where available
• Automatic alert when HbA1c exceeds a defined threshold, prompting a medication review flag on the clinician's dashboard
• Laboratory integration so that results from the facility lab or an external laboratory are posted directly to the patient record without manual transcription

Where HbA1c testing is unavailable (as is still the case in many rural Cameroonian facilities), the system should accommodate serial FPG values as a surrogate, with appropriate clinical decision support guidance.

Blood Pressure Trend Charts for Hypertension

Hypertension management requires consistent, longitudinal blood pressure monitoring. A single blood pressure reading is insufficient — white-coat hypertension, measurement error, and normal day-to-day variation mean that clinical decisions should be based on trends across multiple readings.

An HMS hypertension module captures systolic and diastolic blood pressure at every clinical encounter and presents them as a time-series chart, allowing the clinician to see at a glance whether antihypertensive therapy is achieving the target range (typically below 140/90 mmHg for most adults, below 130/80 mmHg for patients with diabetes or chronic kidney disease).

Persistent uncontrolled hypertension — defined as blood pressure above target on three or more consecutive visits despite medication — should trigger a medication review alert and prompt documentation of the clinical response, whether that is a dose increase, the addition of a second agent, or a referral to specialist care.

Medication Adherence Alerts and Prescription Titration

Medication adherence is the greatest challenge in long-term NCD management. Patients who feel well — as hypertensive patients often do — have less motivation to take daily medication, fill prescriptions on time, or attend clinic reviews. Digital tools can significantly improve adherence rates through systematic monitoring.

Refill Tracking

When the pharmacy module records each antihypertensive or antidiabetic prescription dispensed, the system can calculate the patient's supply duration and generate an alert if they do not return to collect their next supply within the expected window. This "pharmacy refill gap" is a proven, scalable proxy for medication adherence that requires no additional patient-facing technology.

Dose Titration Prompts

Clinical guidelines for hypertension and diabetes include structured titration pathways: if target blood pressure or HbA1c is not reached after a defined period on the current dose, the dose should be increased or a second agent added. An HMS can embed these titration prompts as clinical decision support alerts, reminding the prescribing clinician to review the regimen at each visit rather than passively continuing an ineffective regimen.

Complications Tracking and Risk Stratification

The long-term consequences of poorly controlled diabetes and hypertension — nephropathy, retinopathy, neuropathy, cardiovascular disease, stroke — are preventable with early detection and active management. A digital NCD module must include structured complication screening records.

Recommended annual screening for diabetes patients:

When screening results are captured in the HMS, the system calculates a complication risk score for each patient and adjusts their recommended follow-up frequency accordingly. A patient with early nephropathy and uncontrolled hypertension should be reviewed monthly; a well-controlled patient with no complications might be reviewed every three months — freeing up clinic capacity for those who need it most.

Integrating Chronic Disease Data Into Population Health Management

Beyond individual patient care, digital NCD data enables population health management — the practice of using aggregate data to identify gaps and target interventions across the patient panel. A facility using OPES HMS can generate reports showing:

• The proportion of hypertensive patients with blood pressure at target this quarter versus last quarter
• The number of diabetes patients who are overdue for HbA1c testing
• Geographic clustering of poorly controlled patients, which might indicate a specific community where enhanced outreach is needed
• The distribution of antihypertensive agents in use, which informs procurement planning

These reports can be exported for submission to MINSANTE's NCD surveillance system and can support quality improvement projects applying accreditation standards, enabling facilities to demonstrate measurable improvement in patient outcomes over time.

Barriers to Digital NCD Management in Cameroon

Implementing digital NCD management in Cameroonian health facilities is not without challenges. Key barriers include:

• Connectivity: Many facilities outside Yaoundé and Douala have unreliable internet access. A system that requires continuous connectivity is not viable — offline capability with synchronisation when connectivity is available is essential.
• Staff capacity: Clinicians who have managed NCD patients on paper for years may resist digital workflows. Implementation must include structured training and a transition period during which both paper and digital records are maintained in parallel.
• Patient identity: Without a national unique patient identifier, linking records across facilities for mobile patients is difficult. Biometric enrolment at registration helps but adds infrastructure cost.
• Laboratory integration: Digital NCD management is most powerful when laboratory results flow automatically into the clinical record. Where the laboratory is not yet digitised, manual result entry introduces delay and transcription error.

Each of these barriers is manageable with the right implementation partner and a phased approach to system deployment.

How OPES Health Systems' HMS Chronic Disease Module Works

OPES Health Systems has built chronic disease management into the core architecture of its HMS, recognising that NCD burden in Cameroon is growing faster than acute care infrastructure can accommodate. The chronic disease module provides a structured digital register for diabetes, hypertension, and other NCDs; longitudinal trend charts for glycaemic and blood pressure parameters; medication management with refill tracking and titration prompts; complication screening records with risk stratification; and population-level panel reports.

The module operates fully offline, synchronising with the central server when connectivity is restored — making it viable for district hospitals and health centres in areas with intermittent internet access. Laboratory integration with OPES's lab module means that HbA1c and renal function results post automatically to the patient record without manual entry.

For facilities participating in MINSANTE's NCD surveillance programme, OPES can configure automated report exports in the required format, reducing the reporting burden on facility NCD coordinators. The OPES implementation team provides on-site training and follow-up support to ensure that digital NCD workflows are embedded in clinical practice, not merely adopted on paper and abandoned in practice.

Conclusion

Diabetes and hypertension will define the next generation of healthcare in Cameroon. The patients arriving at clinics today with these conditions will require care for decades, and the quality of that care — the precision of medication titration, the consistency of complication screening, the effectiveness of defaulter tracing — will determine whether they live productive lives or suffer preventable strokes, amputations, and renal failure. Digital chronic disease management is the infrastructure on which that quality of care is built.